发明名称 METHOD OF SCREENING REMEDY FOR HEART FAILURE
摘要 A method of screening a drug having its action point at the Ca<2+> transport controlling mechanism (Ca<2+> pump-phospholamban system) in heart muscle endoplasmic reticulum, i.e., the Ca<2+> storage site in heart muscle cells. More particularly speaking, a method of screening a drug by using the inhibition of the binding of Ca<2+> pump to phospholamban as an indication.
申请公布号 WO0216937(A1) 申请公布日期 2002.02.28
申请号 WO2001JP07008 申请日期 2001.08.13
申请人 YAMAGUCHI TECHNOLOGY LICENSING ORGANIZATION LTD.;TAKEDA CHEMICAL INDUSTRIES, LTD.;UNUI, MAKOTO;KIMURA, YOSHIHIRO 发明人 UNUI, MAKOTO;KIMURA, YOSHIHIRO
分类号 G01N33/50;A61K45/00;A61P9/04;A61P43/00;C12N1/21;C12N15/09;C12P21/02;C12R1/19;G01N33/15;G01N33/68;(IPC1-7):G01N33/50;G01N33/566 主分类号 G01N33/50
代理机构 代理人
主权项
地址